ConductScience.org, home

Paper19603003

Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.

Bridle BW and 7 others. Mol Ther, 2009. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. Papers, record 19603003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19603003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.
PubMed
Journal
Mol Ther
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
1.98
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bridle BWByram W
2Boudreau JEJeanette E
3Lichty BDBrian D
4Brunellière JJérôme
5Stephenson KKyle
6Koshy SSandeep
7Bramson JLJonathan L
8Wan YYonghong

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenoviridaeMajor topic
Cancer VaccinesMajor topic
Genetic VectorsMajor topic
Intramolecular OxidoreductasesMajor topic
MelanomaMajor topic
VesiculovirusMajor topic
Animals
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Female
Humans
Immunization, Secondary
Lung Neoplasms
Mice
Mice, Inbred C57BL
T-Lymphocytes

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19573234Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.J Virol1998https://conductscience.org/library/papers/9573234PubMed
211751399alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.Cancer Res2001https://conductscience.org/library/papers/11751399PubMed
316638862Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.Clin Cancer Res2006https://conductscience.org/library/papers/16638862PubMed
417613256Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression.Immunity2007https://conductscience.org/library/papers/17613256PubMed
58524826Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/8524826PubMed
617513723
Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
J Immunol2007https://conductscience.org/library/papers/17513723PubMed
710757349An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method.Hum Gene Ther2000https://conductscience.org/library/papers/10757349PubMed
912526810Molecular and functional profiling of memory CD8 T cell differentiation.Cell2002https://conductscience.org/library/papers/12526810PubMed
1018971262The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis.J Virol2009https://conductscience.org/library/papers/18971262PubMed
1117616707Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope.Cancer Res2007https://conductscience.org/library/papers/17616707PubMed
1214973051Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin.Cancer Res2004https://conductscience.org/library/papers/14973051PubMed
1315100257CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine.J Immunol2004https://conductscience.org/library/papers/15100257PubMed
149802967Heteroclitic immunization induces tumor immunity.J Exp Med1998https://conductscience.org/library/papers/9802967PubMed
1511752178Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.J Virol2002https://conductscience.org/library/papers/11752178PubMed
1616035952Interleukin (IL)-12 receptor beta1 or IL-12 receptor beta 2 deficiency in mice indicates that IL-12 and IL-23 are not essential for host recovery from viral encephalitis.Viral Immunol2005https://conductscience.org/library/papers/16035952PubMed
1710706699CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.J Immunol2000https://conductscience.org/library/papers/10706699PubMed
1818524170Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.Comp Med2008https://conductscience.org/library/papers/18524170PubMed
199445050An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.J Virol1998https://conductscience.org/library/papers/9445050PubMed
2014585354VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.Cancer Cell2003https://conductscience.org/library/papers/14585354PubMed
218962137Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8962137PubMed

See all 47 referencesDownload CSV of references

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42357627Overcoming Barriers to Clinical Translation: MG1 Maraba Virus as an Emerging Platform for Oncolytic Immunotherapy.Viruses2026https://conductscience.org/library/papers/42357627PubMed
41777881Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective.Front Immunol2026https://conductscience.org/library/papers/41777881PubMed
40474818Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack.Immunotherapy2025https://conductscience.org/library/papers/40474818PubMed
39696625mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy.Biomark Res2024https://conductscience.org/library/papers/39696625PubMed
39609558Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.Nat Biomed Eng2025https://conductscience.org/library/papers/39609558PubMed
39172037Investigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms.J Gen Virol2024https://conductscience.org/library/papers/39172037PubMed
39155294Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies.NPJ Syst Biol Appl2024https://conductscience.org/library/papers/39155294PubMed
38752006Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development.Clin Exp Vaccine Res2024https://conductscience.org/library/papers/38752006PubMed
38710101Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent.Mol Cancer Ther2024https://conductscience.org/library/papers/38710101PubMed
38062315Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment.Med Oncol2023https://conductscience.org/library/papers/38062315PubMed
35387984Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35387984PubMed
35284629Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?Mol Ther Oncolytics2022https://conductscience.org/library/papers/35284629PubMed
35205725Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours.Cancers (Basel)2022https://conductscience.org/library/papers/35205725PubMed
35148469Cancer gene therapy goes viral: viral vector platforms come of age.Radiol Oncol2022https://conductscience.org/library/papers/35148469PubMed
34944889Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin.Cancers (Basel)2021https://conductscience.org/library/papers/34944889PubMed
34315959Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis.Sci Rep2021https://conductscience.org/library/papers/34315959PubMed
34266884Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin.J Immunother Cancer2021https://conductscience.org/library/papers/34266884PubMed
33976179Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.Nat Commun2021https://conductscience.org/library/papers/33976179PubMed
33804676Redirecting the Immune Microenvironment in Acute Myeloid Leukemia.Cancers (Basel)2021https://conductscience.org/library/papers/33804676PubMed
33772027Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.Nat Commun2021https://conductscience.org/library/papers/33772027PubMed

See all 74 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
DCT1638PubTator's text mininghttps://conductscience.org/library/genes/1638NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19603003

GET https://conductscience.org/api/papers/v1/19603003/references?page=2